With nearly $1 billion under management, Galen Partners focuses on equity investments in healthcare information technology, medical devices, and specialty pharmaceutical companies. They actively participate as a lead investor, providing between $10 million to $30 million of equity capital to healthcare-related companies with established revenue. Galen has a successful track record of partnering with management teams to build large, sustainable businesses, leveraging their healthcare experience and industry relationships. They have invested in over 70 companies since 1990, including Dow Pharmaceutical Sciences, EduNeering, and MedAssets.